A practical approach to the common issues of too much or too little androgens in women. In addition to covering the traditional topics, such as polycystic ovary disease and hirsutism, this book provides unique insights by highlighting what can be learned from rare androgen disorders in women, or even men.
A practical approach to the field of androgen excess or deprivation in women's health. The content includes multiple viewpoints on the most common disorders in this class, such as polycystic ovary disease , hirsutism and menopausal issues. Each chapter provides a combination of long-lasting clinical principles in the diagnosis and management of these patients along with a state-of-the-art review. This text takes an innovative approach to uncommon conditions (e.g. congenital adrenal hyperplasia, transgender conditions). In addition to presenting clinical insights, and a review of the basic science underpinning these conditions, it focuses on key concepts that can be derived from these rare conditions to the entire field. This book is an essential addition to the library for any busy clinician who is looking for a practical reference guide but also for the sub-specialist who is looking for new and thought-provoking insights in this complex scientific area.
Daugiau informacijos
A thought-provoking collection of state-of-the-art reviews on a broad range of women's conditions linked to androgen excess or deprivation.
| About the editors |
|
vii | |
| Dedication |
|
viii | |
|
|
|
ix | |
| Preface |
|
xi | |
|
Section 1 Managing the basics |
|
|
|
1 Hirsutism: managing the basics |
|
|
1 | (10) |
|
Hector F. Escobar-Morreale |
|
|
2 Alopecia: managing the basics |
|
|
11 | (14) |
|
|
|
|
|
3 Polycystic ovary syndrome: managing the basics |
|
|
25 | (13) |
|
|
|
4 Sexual dysfunction, including hypoactive sexual desire disorder: diagnosis and treatment recommendations |
|
|
38 | (17) |
|
|
|
|
|
Section 2 The scientific essentials |
|
|
|
5 The androgen receptor: basic structure and function |
|
|
55 | (9) |
|
|
|
6 Androgens in postmenopausal women: their practically exclusive intracrine formation and inactivation in peripheral tissues |
|
|
64 | (10) |
|
|
|
7 Diagnostic criteria of polycystic ovary syndrome |
|
|
74 | (5) |
|
|
|
|
|
8 Androgen effects on the skin |
|
|
79 | (10) |
|
|
|
|
|
9 Polycystic ovary syndrome and cardiovascular risk |
|
|
89 | (8) |
|
|
|
|
|
10 Effects of androgens on female genital tract |
|
|
97 | (14) |
|
|
|
|
|
Section 3 Learning from the extremes |
|
|
|
11 Congenital adrenal hyperplasia in females |
|
|
111 | (7) |
|
|
|
|
|
12 Cushing's syndrome in females |
|
|
118 | (18) |
|
|
|
|
|
|
|
13 Androgen-producing ovarian tumors |
|
|
136 | (10) |
|
|
|
14 Cognitive and behavioral impact of androgen disorders in females: learning from complete androgen insensitivity syndrome and congenital adrenal hyperplasia |
|
|
146 | (5) |
|
|
|
15 Testosterone replacement in the aging male: lessons learned from the Women's Health Initiative |
|
|
151 | (10) |
|
|
|
|
|
|
|
|
16 History and physical examination of polycystic ovary syndrome: detecting too much or too little |
|
|
161 | (19) |
|
|
|
|
|
|
|
17 Androgen assays: of mice and men |
|
|
180 | (11) |
|
|
|
18 Magneticresonance imaging of the adrenal gland |
|
|
191 | (9) |
|
|
|
|
|
19 Androgens and DHEA in postmenopausal medicine |
|
|
200 | (8) |
|
|
|
|
|
20 Lifestyle, diet, and exercise in polycystic ovary syndrome |
|
|
208 | (8) |
|
|
|
|
|
21 Polycystic ovary syndrome ovulation induction |
|
|
216 | (10) |
|
|
|
22 Ovulation induction in women with polycystic ovary syndrome |
|
|
226 | (7) |
|
|
|
|
| Index |
|
233 | |
Leo Plouffe, Jr is Vice President, Global Pharmacovigilance, and Head, Risk Management, Bayer HealthCare Pharmaceuticals, Whippany, NJ, USA. Botros R. M. B. Rizk is Professor of Obstetrics and Gynecology and Director of the Division of Reproductive Endocrinology and Infertility, University of South Alabama College of Medicine, Mobile, AL, USA.
Daugiau apie elektronines knygas